Lexaria Receives Notice of its First Patent to be Granted in Australia for Cannabinoid Infused Edibles KELOWNA, BC--(Marketwired - February 27, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") is pleased to announce it has received a Notice of Acceptance from the...

Lexaria Signs Master Collaborative Research Agreement KELOWNA, BC--(Marketwired - February 08, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) ("the Company" or "Lexaria"), through its wholly owned Canadian subsidiary Lexaria Canpharm Corp.,...

Lexaria and NeutriSci Announce Successful Cannabinoid Tablet Development and Positive Results From Initial Human Observational Trials KELOWNA, BC--(Marketwired - January 19, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") and NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX...

Lexaria Files International Cannabinoid Patent Applications KELOWNA, BC--(Marketwired - December 19, 2016) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") is pleased to announce, following the successful October 26, 2016...